WEARABLE AUTO-INJECTION SYSTEMS AND METHODS

Smart overview of the Invention

A wearable device designed for autonomous anaphylaxis treatment integrates advanced physiological monitoring, artificial intelligence, and automated drug delivery. It continuously tracks respiratory, cardiovascular, and autonomic functions using multiple sensors. The device's processor establishes personalized baseline values and detects deviations through pattern recognition, identifying anaphylactic episodes by analyzing concurrent respiratory distress and cardiovascular shock conditions. The system includes a spring-actuated mechanism for intramuscular epinephrine injection, ensuring prompt treatment without manual intervention. Safety features such as alert notifications and a single-dose lockout enhance user security.

Technical Field

The invention pertains to wearable medical devices that autonomously monitor health and provide emergency interventions. Specifically, it focuses on systems integrating multi-modal physiological sensing, AI-based diagnostics, and automated drug delivery mechanisms for anaphylaxis treatment. The device's layered architecture combines sensors, electronics, drug delivery, and power management in a compact form, suitable for continuous protection during daily activities.

Background

Anaphylaxis is a severe allergic reaction affecting millions annually, with rapid onset symptoms such as blood pressure drops and airway obstruction. Traditional treatment relies on manual epinephrine auto-injectors, which often face challenges like delayed recognition and user hesitation. Existing wearable devices track vital signs but lack therapeutic intervention capabilities, while conventional auto-injectors require manual operation. Current technologies fail to integrate monitoring and intervention, highlighting the need for improved systems that autonomously handle anaphylaxis detection and treatment.

Innovative Features

The device features integrated components for physiological monitoring, intelligent diagnostics, and automated drug delivery. Sensors continuously assess respiratory, cardiovascular, and autonomic functions, while a processor analyzes data to identify anaphylactic conditions. The system triggers an epinephrine injection when predefined criteria are met, confirmed by safety interlocks. The wearable unit includes layers for skin contact, drug reservoirs, mechanical actuators, and electronics, ensuring seamless operation and emergency response without user intervention.

Methodology

The method involves continuous physiological monitoring and baseline calibration to detect multi-system conditions. Respiratory distress and cardiovascular shock are identified through specific sensor data patterns. A confidence score system determines the likelihood of anaphylaxis, triggering drug delivery when thresholds are surpassed. The wearable device delivers therapeutic agents intramuscularly, ensuring autonomous emergency treatment during anaphylactic episodes, with additional variations and enhancements outlined in the detailed description.